scholarly article | Q13442814 |
P356 | DOI | 10.3109/10520295.2014.965276 |
P698 | PubMed publication ID | 25297562 |
P50 | author | Abel García-García | Q37837089 |
Mario Pérez Sayáns | Q43904511 | ||
Pilar Gandara Vila | Q51680043 | ||
Pilar Gayoso-Diz | Q64683482 | ||
José Manuel Suárez-Peñaranda | Q71774909 | ||
F Barros-Angueira | Q114563088 | ||
P2093 | author name string | C T Supuran | |
M Gallas-Torreira | |||
M Torres-López | |||
P2860 | cites work | A novel quasi-viral agent, MaTu, is a two-component system | Q28209256 |
Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up | Q33447858 | ||
Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management | Q33544076 | ||
A review of the nonsurgical treatment of oral leukoplakia | Q33720658 | ||
Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa | Q34116632 | ||
Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. | Q34632270 | ||
Progress in determining the malignant potential of oral lesions | Q35106813 | ||
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers | Q35132130 | ||
Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics | Q35134845 | ||
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer | Q35167920 | ||
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. | Q35746400 | ||
Nomenclature and classification of potentially malignant disorders of the oral mucosa | Q36974891 | ||
Natural history of potentially malignant oral lesions and conditions: an overview of the literature | Q37043659 | ||
Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement | Q37077759 | ||
The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder | Q37145181 | ||
Expression of the cell cycle regulation proteins p53 and p21WAF1 in different types of non-dysplastic leukoplakias. | Q37437569 | ||
Genetic and molecular alterations associated with oral squamous cell cancer (Review). | Q37626579 | ||
Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism | Q37740182 | ||
Carbonic anhydrase inhibitors and activators for novel therapeutic applications | Q37909406 | ||
Interfering with pH regulation in tumours as a therapeutic strategy | Q37933052 | ||
Hypoxia-inducible factors in OSCC. | Q37940756 | ||
The role of carbonic anhydrase IX in hypoxia control in OSCC. | Q37993617 | ||
Chondrosarcoma of the distal phalanx of the right great toe: report of a rare malignancy and review of literature | Q38005289 | ||
Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma. | Q38395239 | ||
A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. | Q38476637 | ||
Oral leukoplakia | Q40406090 | ||
Evaluation of glutathione S-transferase activity in human buccal epithelial dysplasias and squamous cell carcinomas | Q40893794 | ||
Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions | Q41007002 | ||
Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation | Q42148565 | ||
MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker | Q42439841 | ||
Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX*1 | Q44095114 | ||
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides | Q44366527 | ||
The clinical determinants of malignant transformation in oral epithelial dysplasia. | Q44498677 | ||
Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-β: but p53 mutations are not necessarily required | Q44637351 | ||
Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? | Q45248232 | ||
Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients. | Q47928743 | ||
The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma. | Q50858057 | ||
Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. | Q53342633 | ||
Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. | Q53399969 | ||
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma | Q57377955 | ||
Genetic portrait of mild and severe lingual dysplasia | Q57765119 | ||
Salivary markers of oxidative stress in patients with oral premalignant lesions | Q57825999 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | oral mucosa leukoplakia | Q18558187 |
P304 | page(s) | 124-131 | |
P577 | publication date | 2014-10-09 | |
P1433 | published in | Biotechnic & Histochemistry | Q4915326 |
P1476 | title | The use of CA-IX as a diagnostic method for oral leukoplakia | |
P478 | volume | 90 |
Search more.